Smoking Cessation Intervention in Respiratory Inpatients

PHASE4CompletedINTERVENTIONAL
Enrollment

101

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Pulmonary Disease, Chronic ObstructiveAsthmaCommunity Acquired Pneumonia
Interventions
DRUG

Varenicline

Varenicline was given for 12 weeks to all patients in group A. The initial dose was 0.5 mg/day for days 1-3, and was then up-titrated to 0.5mg on days 4-7, and finally to 1 mg twice daily from day 8 until the end of treatment

BEHAVIORAL

Behavioral support

An initial private consultation session and motivational interview while still in the hospital that lasted for at least 60 minutes. Follow-up phone calls with a minimum duration of 10 minutes were scheduled in weeks 1, 2, 4, and months 3,6 and 9 following smoking cessation.

All Listed Sponsors
collaborator

University of Thessaly

OTHER

lead

General Hospital of Kavala

OTHER

NCT02922387 - Smoking Cessation Intervention in Respiratory Inpatients | Biotech Hunter | Biotech Hunter